Top Markets
#1 Islamic Coin Islamic Coin +155.79%
#2 Siren Siren +36.02%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.66%
#4 Arowana Arowana +18.81%
#5 Cysic Cysic +17.29%
#6 PulseChain PulseChain +16.52%
#7 Wiki Cat Wiki Cat +14.55%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.32%
#9 The Grays Currency The Grays Currency +13.90%
#10 KUB Coin KUB Coin +13.38%
Coin of the day
Islamic Coin Islamic Coin
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Organicell Regenerative Medicine, Inc. Organicell Regenerative Medicine, Inc.

Organicell Regenerative Medicine, Inc.

OCEL
शेयरों में रैंक #31544
Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical... Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.
शेयर मूल्य
$1.77
अंतिम समन्वयन: 2024-04-02
मार्केट कैप
$12.89M
बदलाव (1 दिन)
-11.50%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Organicell Regenerative Medicine, Inc. (OCEL)

श्रेणी

Healthcare
Organicell Regenerative Medicine, Inc. (OCEL) के लिए P/B अनुपात
2026 को P/B अनुपात TTM: 0
Organicell Regenerative Medicine, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0 है। 2026 के अंत में, कंपनी का P/B अनुपात 0 था।
Organicell Regenerative Medicine, Inc. के लिए 2026 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
प्रदान की गई तारीखों के लिए पर्याप्त डेटा नहीं।
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR